Posted in | News | Rubber and Elastomer

Goodyear Completes Sale of North American Farm Tire Assets

The Goodyear Tire & Rubber Company today announced it has completed the previously announced sale of its North American farm tire assets to Titan Tire Corporation, a subsidiary of Titan International, Inc.

The sale includes Goodyear's farm tire manufacturing plant, property and equipment in Freeport, Ill., and inventories. It also includes a licensing agreement with Titan to pay a royalty to manufacture and sell Goodyear-branded farm tires in North America.

Goodyear received $100 million from Titan for the assets. It expects to record a loss of approximately $65 million on the sale, including charges for the curtailment of employee pension and post-retirement medical plans, of which approximately $60 million will be recorded during the fourth quarter of 2005 and the remainder will be recorded during 2006.

On an on-going basis, the sale will reduce revenue in Goodyear's North American Tire segment by about $200 million annually, but will eliminate the need for further investment in the farm tire business and position the company to enhance the segment's profitability.

"Goodyear tires have been a vital part of the American farm for nearly a century," said Jonathan D. Rich, president of the company's North American Tire business. "This transaction helps that relationship continue and allows us to increase our focus on our core consumer and commercial tire businesses."

Rich expressed his confidence that Titan Tire, for whom farm tires are a core business, will seek to maintain relationships with Goodyear farm tire dealers and the farming community.

"I thank our farm tire associates and dealers for their many years of service and support," he added.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.